Scientific publications
Targeting Metallo-β-Lactamase Endemicity: Activity of Novel Meropenem-pilabactam in Combination with Aztreonam Against Contemporary Enterobacterales
Lucia Maccari, Mariano Echegorry, Diego Faccone, Juan De Mendieta, Melina Rapoport, Celeste Lucero, Ezequiel Albornoz, Paola Ceriana, Alejandra Corso, Fernando Pasteran
In Vitro Activity of Meropenem-pilabactam and Comparators Against Carbapenem-Resistant Acinetobacter Clinical Isolates: Implications for Low- and Middle-Income Countries (LMIC)
Lucia Maccari, Mariano Echegorry, Miguel Dumas, María Teresita Soto, María José Cima Clave, Ezequiel Albornoz, Paola Ceriana, Alejandra Menocal, Alejandra Corso, Fernando Pasteran
Meropenem-pilabactam (ANT3310): A Novel Agent Targeting Serine Carbapenemase-Producing Enterobacterales
M. Echegorry, L. Maccari, P. Ceriana, M Rapoport, C. Lucero, MA Menocal, A. Corso, F. Pasteran
High-Potency of the Novel Therapeutic Combination Meropenem/Pilabactam (Formerly Meropenem/ANT3310) Against KPC β-Lactamase Variants Driving Resistance to Ceftazidime/Avibactam
Salud Rodríguez-Pallares, Lucía Sánchez-Peña, Cristina Elías-López, Roberto Rilo-Antelo, Tania Blanco-Martín, Gloria Pérez-Rodríguez, Lucía González Pinto, Agustina Llanos, Alejandro Beceiro, Germán Bou, Jorge Arca-Suárez
Pharmacokinetics-Pharmacodynamics of ANT3310, in Combination with Meropenem, Against Carbapenem-Resistant Acinetobacter baumannii Using a Neutropenic Murine-Pneumonia Model
B.D. VanScoy, A.N. Seyfried, M. Nasman, A.S. MacGregor, D. Gillman, C.M. Rubino, S.M. Bhavnani, M. Zalacain, J. Dao, R. Pypstra, P.G. Ambrose
Pharmacokinetics, Safety and Tolerability of Pilabactam (formerly ANT3310) Combined with Meropenem in Participants with Impaired Renal Function
J. Dao, C. Zwingelstein, A.C. Benichou, L. Fabre, B. Chukwumezie
Penetration of Pilabactam (Formerly ANT3310) and Meropenem into Pulmonary Epithelial Lining Fluid in Healthy Adult Participants
J. Dao, C. Zwingelstein, A.C. Benichou, L. Fabre, K. Rodvold, M. Gotfried, J. Burr Ross
Potent Activity of the Novel Combination Meropenem-pilabactam (Formerly ANT3310) Against Global Acinetobacter baumannii Clinical Isolates from 2019 to 2023
C. Da Silva, A. Alary, M.I. Ancora, M. Estel Wattel, S. Hawser, M. Hackel, A. Ledoux, M. Lemonnier, M. Zalacain, A. Llano
Potent Activity of the Novel Combination Meropenem-pilabactam (Formerly ANT3310) Against Global OXA- and KPC-Carbapenem-Resistant Enterobacterales (CRE) Clinical Isolates from 2019 to 2023
C. Da Silva, A. Alary, M.I. Ancora, S. Hawser, M. Hackel, A. Ledoux, M. Lemonnier, M. Zalacain, A. Llanos